MOMENTUM 3 Continued Access Protocol

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1685 participants.

Also called NCT02892955

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,685 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02892955
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02892955. Allocation not applicable; no masking; primary purpose treatment. Start 2016-08 (actual); primary completion 2020-12 (actual). Results posted on 2022-03-03.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MOMENTUM 3 Continued Access Protocol
Acronym
MOMENTUM 3 CAP
Condition
Advanced Refractory Left Ventricular Heart Failure
Intervention (Device)
HeartMate 3 LVAS
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct02892955
Content hash
1393ff59b6cac1753d963e71a9cd56d2c5ebdcb40509924d141447ab3a005490